Anagha Medsinge, MD | |
101 Manning Dr, Chapel Hill, NC 27514-4220 | |
(984) 974-2020 | |
Not Available |
Full Name | Anagha Medsinge |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 25 Years |
Location | 101 Manning Dr, Chapel Hill, North Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578944831 | NPI | - | NPPES |
2019-01007 | Other | NC | MEDICAL BOARD LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 2019-01007 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Upmc Mercy | Pittsburgh, PA | Hospital |
Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Everett And Hurite Ophthalmic Association | 6103720560 | 15 |
News Archive
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.
Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A study by investigators at Mayo Clinic, Wayne State University and Johns Hopkins Medicine shows that steroids attached to the dendrimers target the damage-causing cells associated with neuroinflammation, leaving the rest of the eye unaffected and preserving vision.
A team of researchers led by Dr. Jayakrishna Ambati at the University of Kentucky has discovered a biological marker for neovascular age-related macular degeneration (AMD), the leading cause of blindness in older adults.
People who identify as African-American may be as little as 1 percent West African or as much as 99 percent, just one finding of a large-scale, genome-wide study of African and African-American ancestry released today.
› Verified 2 days ago
Entity Name | Everett & Hurite Ophthalmic Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225146228 PECOS PAC ID: 6103720560 Enrollment ID: O20040412000778 |
News Archive
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.
Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A study by investigators at Mayo Clinic, Wayne State University and Johns Hopkins Medicine shows that steroids attached to the dendrimers target the damage-causing cells associated with neuroinflammation, leaving the rest of the eye unaffected and preserving vision.
A team of researchers led by Dr. Jayakrishna Ambati at the University of Kentucky has discovered a biological marker for neovascular age-related macular degeneration (AMD), the leading cause of blindness in older adults.
People who identify as African-American may be as little as 1 percent West African or as much as 99 percent, just one finding of a large-scale, genome-wide study of African and African-American ancestry released today.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Anagha Medsinge, MD 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517-9638 Ph: (984) 974-2020 | Anagha Medsinge, MD 101 Manning Dr, Chapel Hill, NC 27514-4220 Ph: (984) 974-2020 |
News Archive
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.
Hitching a ride into the retina on nanoparticles called dendrimers offers a new way to treat age-related macular degeneration and retinitis pigmentosa. A study by investigators at Mayo Clinic, Wayne State University and Johns Hopkins Medicine shows that steroids attached to the dendrimers target the damage-causing cells associated with neuroinflammation, leaving the rest of the eye unaffected and preserving vision.
A team of researchers led by Dr. Jayakrishna Ambati at the University of Kentucky has discovered a biological marker for neovascular age-related macular degeneration (AMD), the leading cause of blindness in older adults.
People who identify as African-American may be as little as 1 percent West African or as much as 99 percent, just one finding of a large-scale, genome-wide study of African and African-American ancestry released today.
› Verified 2 days ago
Alexis Renee Pascoe, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517 Phone: 984-974-2020 | |
Dr. Paul Singer, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-4131 | |
Dr. Donald L Budenz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5151 Bioinformatics, Cb 7040, Chapel Hill, NC 27599 Phone: 919-843-0297 | |
Christopher Jaeyon Hwang, MD, MPH Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517 Phone: 984-974-2020 | |
Kathleen G Gordon, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Unc Ch Department Of Ophthalmology, 130mason Farm Rd, 5151 Bioinformatics, Chapel Hill, NC 27599 Phone: 919-966-5296 Fax: 919-966-1908 | |
Dr. Rachel A Tesser, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 55 Vilcom Center Circle, Suite 110, Chapel Hill, NC 27514 Phone: 919-960-2720 Fax: 919-960-2721 | |
Steven Brent Flynn, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2226 Nelson Hwy Ste 200, Chapel Hill, NC 27517 Phone: 984-974-2020 |